Alves told the Investing News Network (INN) about the way the company plans to approach its biggest upcoming market development: the legalization of edibles and infused products in Canada.
Alves is replacing Chuck Rifici as CEO. Rifici, one of the co-founders of Canopy Growth (NYSE:CGC,TSX:WEED) and chairman of Auxly, will now have time to act entirely as an ambassador for the cannabis company and make sure Auxly’s partnerships are working correctly, according to Alves.
While a new top executive might lead to expectations of a new strategy for the company, Alves has been a steady presence with Auxly since the start; he said the plans for the company remain the same.
When it comes to the focus of the company, Alves knows October 17 represents a significant date for Auxly with the introduction of edibles and infused products in Canada.
The second stage of legalization, more commonly referred to as cannabis 2.0 or legalization 2.0, will allow all producers in the country to sell novelty items, such as vape pens and edible gummies.
All of these products are expected to produce returns of C$2.7 billion per year, according to Deloitte.
“We’re focused on bringing branded derivative products to consumers, to the cannabis 2.0 market. We’ve been focused on that now for probably well over a year,” Alves told INN.
The new CEO also identified this new legalization phase as a reset for the entire Canadian industry, which has struggled in the investment market as the rollout of adult-use products continues in Canada.
Edibles legalization opens door to brand partnerships
In July, Alves and Michael Lickver, senior vice president of strategy at Auxly, left their positions on the board of Dixie Brands (CSE:DIXI.U,OTCQX:DXBRF), an established partner of Auxly. Alves explained that this decision was planned ahead of his succession as Auxly’s CEO.
However, he confirmed there will be no change in direction between the two firms. Auxly holds the rights to Dixie products and it fully intends to bring those up north at the launch of legalization 2.0.
“We’ve got to make sure that the same Dixie product you buy in Denver, if you buy it in Canada it tastes the same (and) it feels the same,” Alves explained. He added that these products must still follow the regulatory guidelines of Canada compared to other US state-level markets.
Alves told INN the Dixie-branded products will not represent the bulk of edible and infused offerings the company plans to sell once these products become available in Canada.
“Dixie is another brand there and we will have a variety of SKUs for the Dixie brand. But in terms of us relying on the Dixie brand as our primary brand under which we offer derivative products, that won’t be the case,” he said.
In a previous interview with INN, Chuck Smith, CEO of Dixie, said it’s still too early to pinpoint which specific products will be initially available in Canada. However, the company wants all its products and brands to be available eventually.
The investment consists of a total deal worth C$123 million by way of a debenture structured in a three year term with a fixed annual interest rate of 4 percent.
Alves said this investment arrived at the perfect time for his company. He sees the transaction as more than an investment in Imperial Brands. The two firms will collaborate through Imperial’s vaping technology subsidiary, Nerudia, to expand the capabilities of Auxly in the Canadian market.
“I think it’s a huge validation for our vision, our assets and capabilities and strategy to execute on that vision,” said Alves. “And I think for the broader industry it really validates the tremendous growth opportunity that cannabis presents.”
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.
In the evolving rush of mergers and acquisitions (M&A) in the Canadian cannabis market, Canopy Growth (NASDAQ:CGC,TSX:WEED) announced it will acquire The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) in a deal worth approximately C$435 million.
Meanwhile, a cannabis operator in the US confirmed this week that it will receive a financial boost from a partner to solidify its position in the burgeoning Pennsylvania state market.
The Board of Directors of Aphria Unanimously Recommends Shareholders Vote “For” the Arrangement
Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination
Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), one of the UK’s leading CBD and Hemp product suppliers, announces that as part of the equity fundraise announced yesterday, Antony Calamita and Andrew Male, Directors of the Company, subscribed for 285,714 Ordinary Shares and 1,428,571 Ordinary Shares respectively. The subscriptions are at a price of 3.5 pence per ordinary share for a total of £60,000. Following these subscriptions, Antony Calamita is now interested in 54,385,714 Ordinary Shares, representing 8.61% of the Company’s share capital as increased by the fundraising, and Andrew Male is now interested in 6,138,196 Ordinary Shares, representing 0.97% of the Company’s issued share capital as increased by the fundraising
Further, the timetable for receipt of applications under the Broker Option, which was also announced yesterday, has been extended until 5:00 pm 9 April 2021 to capture additional interest which was unable to be completed yesterday.
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, would like to provide the following dial-in information for the Company’s upcoming Annual and Special Meeting (the “Meeting”) scheduled to be held at 11:00 a.m. Eastern Daylight Time on April 12, 2021. Shareholders and proxyholders may access the Meeting via teleconference by dialing 647-723-3984 or 1-866-365-4406 from Canada or the United States, then entering participation code “8487744” followed by the pound (“#”) sign.
In consideration of the COVID-19 pandemic and the recent restrictions imposed by the Ontario Provincial Government, shareholders and proxyholders will only be able to attend the Meeting via teleconference and will not be permitted to attend the Meeting in person at the address provided on the Notice of Annual and Special Meeting of Shareholders.
Gage Cannabis Announces Exclusive Partnership With Blue River to Bring Award-Winning Cannabis Extracts to Michigan
Gage Growth Corp. (“Gage” or the “Company”) (CSE:GAGE), a leading high-quality craft cannabis brand and operator in Michigan, announced today that it has signed an agreement with Blue River™ Extracts & Terpenes (“Blue River™”) to bring the brand’s award-winning solventless technology and other trademark branded products to the state’s medical patients and cannabis consumers. The Company will have exclusive rights to Blue River™’s premium product offerings in Michigan.